BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34408923)

  • 21. Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.
    Stein A; Panjwani A; Sison C; Rosen L; Chugh R; Metz C; Bank M; Bloom O
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1498-507. PubMed ID: 23618747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma.
    Zhang L; Ye SB; Ma G; Tang XF; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
    J Transl Med; 2013 Mar; 11():60. PubMed ID: 23497377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
    Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V
    Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation factors in hepatoblastoma and their clinical significance as diagnostic and prognostic biomarkers.
    Guo F; Ru Q; Zhang J; He S; Yu J; Zheng S; Wang J
    J Pediatr Surg; 2017 Sep; 52(9):1496-1502. PubMed ID: 28188039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia.
    Okazaki S; Hishimoto A; Otsuka I; Watanabe Y; Numata S; Boku S; Shimmyo N; Kinoshita M; Inoue E; Ohmori T; Someya T; Sora I
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():33-41. PubMed ID: 29305329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients.
    Wang SC; Parekh JR; Porembka MR; Nathan H; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Jarnagin WR; Allen PJ
    J Gastrointest Surg; 2016 May; 20(5):899-904. PubMed ID: 26921028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
    Zhao YM; Wang L; Dai Z; Wang DD; Hei ZY; Zhang N; Fu XT; Wang XL; Zhang SC; Qin LX; Tang ZY; Zhou J; Fan J
    Int J Cancer; 2011 Nov; 129(10):2463-72. PubMed ID: 21213214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.
    Ren Y; Law S; Huang X; Lee PY; Bacher M; Srivastava G; Wong J
    Ann Surg; 2005 Jul; 242(1):55-63. PubMed ID: 15973102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum Levels of Migration Inhibitory Factor (MIF) and
    Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
    Front Immunol; 2018; 9():246. PubMed ID: 29487601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance and dynamic change of plasma macrophage migration inhibitory factor in patients with acute ST-elevation myocardial infarction.
    Deng F; Zhao Q; Deng Y; Wu Y; Zhou D; Liu W; Yuan Z; Zhou J
    Medicine (Baltimore); 2018 Oct; 97(43):e12991. PubMed ID: 30412132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage migration inhibitory factor, a role in COPD.
    Husebø GR; Bakke PS; Grønseth R; Hardie JA; Ueland T; Aukrust P; Eagan TM
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L1-7. PubMed ID: 27190066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation.
    Gando S; Sawamura A; Hayakawa M; Hoshino H; Kubota N; Nishihira J
    Inflammation; 2007 Aug; 30(3-4):118-24. PubMed ID: 17534704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing chronic pelvic pain syndrome patients: blood plasma factors and cortisol saliva.
    Lundh D; Hedelin H; Jonsson K; Gifford M; Larsson D
    Scand J Urol; 2013 Dec; 47(6):521-8. PubMed ID: 23394140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion.
    Li JH; Tang Y; Lv J; Wang XH; Yang H; Tang PMK; Huang XR; He ZJ; Zhou ZJ; Huang QY; Klug J; Meinhardt A; Fingerle-Rowson G; Xu AP; Zheng ZH; Lan HY
    J Cell Mol Med; 2019 Jun; 23(6):3867-3877. PubMed ID: 30968541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma.
    Byrling J; Hilmersson KS; Ansari D; Andersson R; Andersson B
    Clin Transl Oncol; 2022 Feb; 24(2):297-304. PubMed ID: 34319497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile.
    Avalos-Navarro G; Muñoz-Valle JF; Daneri-Navarro A; Quintero-Ramos A; Franco-Topete RA; Morán-Mendoza AJ; Oceguera-Villanueva A; Bautista-Herrera LA; Topete-Camacho A; Del Toro-Arreola A
    Clin Exp Med; 2019 Aug; 19(3):385-391. PubMed ID: 31102004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
    Pei XJ; Wu TT; Li B; Tian XY; Li Z; Yang QX
    Int J Med Sci; 2014; 11(1):106-15. PubMed ID: 24396292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells.
    Denz A; Pilarsky C; Muth D; Rückert F; Saeger HD; Grützmann R
    J Surg Res; 2010 May; 160(1):29-34. PubMed ID: 19726058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
    Koh HM; Kim DC; Kim YM; Song DH
    Thorac Cancer; 2019 Dec; 10(12):2209-2217. PubMed ID: 31602798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.